AGENUS INC Public Float
AGENUS INC (AGEN) had Public Float of $135.40 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $135.40M.
- 2024-06-28: Entity Public Float $351.60M.
- 2023-06-30: Entity Public Float $583.50M.
- 2022-06-30: Entity Public Float $544.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $135.40M 10-K · filed 2026-03-16 |
| 2024-06-28 | $351.60M 10-K · filed 2025-03-17 |
| 2023-06-30 | $583.50M 10-K · filed 2024-03-14 |
| 2022-06-30 | $544.10M 10-K · filed 2023-03-16 |
| 2021-06-30 | $1.23B 10-K · filed 2022-03-01 |
| 2020-06-30 | $670.50M 10-K · filed 2021-03-16 |
| 2019-06-28 | $406.80M 10-K · filed 2020-03-16 |
| 2018-06-29 | $194.00M 10-K · filed 2019-03-18 |
| 2017-06-30 | $306.40M 10-K · filed 2018-03-16 |
| 2016-06-30 | $287.30M 10-K · filed 2017-03-16 |
| 2015-06-30 | $571.00M 10-K · filed 2016-03-15 |
| 2014-06-30 | $147.30M 10-K · filed 2015-03-16 |
| 2013-06-30 | $87.10M 10-K · filed 2014-03-07 |
| 2012-06-30 | $115.80M 10-K · filed 2013-03-18 |
| 2011-06-30 | $75.90M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |